These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17545613)

  • 21. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
    Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S
    Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-gamma (MIG) gene expression in B-cell malignancy.
    Uranishi M; Iida S; Sanda T; Ishida T; Tajima E; Ito M; Komatsu H; Inagaki H; Ueda R
    Leukemia; 2005 Aug; 19(8):1471-8. PubMed ID: 15959530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cells.
    Mankaï A; Bordron A; Renaudineau Y; Martins-Carvalho C; Takahashi S; Ghedira I; Berthou C; Youinou P
    Cancer Res; 2008 Sep; 68(18):7512-9. PubMed ID: 18794139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
    Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI
    Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
    Weigelt K; Ernst W; Walczak Y; Ebert S; Loenhardt T; Klug M; Rehli M; Weber BH; Langmann T
    J Leukoc Biol; 2007 Dec; 82(6):1564-74. PubMed ID: 17827340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GnT-V expression and metastatic phenotypes in macrophage-melanoma fusion hybrids is down-regulated by 5-Aza-dC: evidence for methylation sensitive, extragenic regulation of GnT-V transcription.
    Chakraborty AK; Sousa Jde F; Chakraborty D; Funasaka Y; Bhattacharya M; Chatterjee A; Pawelek J
    Gene; 2006 Jun; 374():166-73. PubMed ID: 16556489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation and chromatin structure regulate PU.1 expression.
    Amaravadi L; Klemsz MJ
    DNA Cell Biol; 1999 Dec; 18(12):875-84. PubMed ID: 10619599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
    Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
    PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer.
    Okami J; Simeone DM; Logsdon CD
    Cancer Res; 2004 Aug; 64(15):5338-46. PubMed ID: 15289340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
    Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
    Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the PU.1 gene by distal elements.
    Li Y; Okuno Y; Zhang P; Radomska HS; Chen H; Iwasaki H; Akashi K; Klemsz MJ; McKercher SR; Maki RA; Tenen DG
    Blood; 2001 Nov; 98(10):2958-65. PubMed ID: 11698277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia.
    Steidl U; Steidl C; Ebralidze A; Chapuy B; Han HJ; Will B; Rosenbauer F; Becker A; Wagner K; Koschmieder S; Kobayashi S; Costa DB; Schulz T; O'Brien KB; Verhaak RG; Delwel R; Haase D; Trümper L; Krauter J; Kohwi-Shigematsu T; Griesinger F; Tenen DG
    J Clin Invest; 2007 Sep; 117(9):2611-20. PubMed ID: 17694175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter hypermethylation of tetraspanin members contributes to their silencing in myeloma cell lines.
    Drucker L; Tohami T; Tartakover-Matalon S; Zismanov V; Shapiro H; Radnay J; Lishner M
    Carcinogenesis; 2006 Feb; 27(2):197-204. PubMed ID: 16113057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma.
    Chen G; Wang Y; Huang H; Lin F; Wu D; Sun A; Chang H; Feng Y
    Eur J Haematol; 2009 Mar; 82(3):176-83. PubMed ID: 19077051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis.
    Hodge DR; Xiao W; Peng B; Cherry JC; Munroe DJ; Farrar WL
    Cancer Res; 2005 Jul; 65(14):6255-63. PubMed ID: 16024627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
    Boissy P; Andersen TL; Abdallah BM; Kassem M; Plesner T; Delaissé JM
    Cancer Res; 2005 Nov; 65(21):9943-52. PubMed ID: 16267019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using PU.1 and Jun dimerization protein 2 transcription factor expression in myelodysplastic syndromes to predict treatment response and leukaemia transformation.
    Boasman K; Simmonds MJ; Graham C; Saunthararajah Y; Rinaldi CR
    Ann Hematol; 2019 Jun; 98(6):1529-1531. PubMed ID: 30721335
    [No Abstract]   [Full Text] [Related]  

  • 39. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
    Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
    J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia.
    Yang H; Liang H; Yan JS; Tao R; Hao SG; Ma LY
    Int J Hematol; 2012 Jul; 96(1):65-73. PubMed ID: 22674382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.